Delivery Order SPE2DB20D2014-SPE2DB24FC46B

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Repatha 140 mg/ml SureClick autoinjectors to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract, valued at $1,814.17, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company that serves as a prime contractor for various government agencies. The contract is a firm-fixed price Delivery Order under an Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of Repatha 140 mg/ml SureClick injectors to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distributors in the world. The contract has a ceiling value of $4,807.89 and is a firm fixed-price delivery order with an ultimate completion date of April 25, 2024. Amerisourcebergen also...
This federal contract award is for the delivery of Repatha 140 mg/ml SureClick autoinjectors to support the Medical Supply Chain program of the Defense Logistics Agency (DLA). The contract, awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a firm fixed-price delivery order valued at $5,761.28. The contract has an ultimate completion date of May 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA). The $7,167.57 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Repatha 140 mg/mL SureClickTM medication to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The $1,016.82 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is for the delivery of Repatha 140 mg/ml SureClick auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $11,824.27, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 15, 2023, with a completion date of May 16, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued...
This federal contract award is for the delivery of Repatha 140 mg/mL SureClick Autoinjector, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $34,127.23 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The award has an ultimate completion date of January 4, 2023 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of Repatha 140 mg/ml SureClick injector pens to the Defense Logistics Agency (DLA). The contract, valued at $1,016.82, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 5, 2024 and is a firm fixed-price delivery order. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant...
This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) covers the delivery of Repatha 140 mg/ml SureClick autoinjector medication. The $2,033.64 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $6,078.90 to provide Repatha 140 mg/ml SureClick Autoinjectors. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a comprehensive vehicle for the company to supply a range of pharmaceutical products and medical supplies...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC46B
    Delivery Order

This federal contract award is for the delivery of Repatha 140 mg/mL SureClick autoinjector medication to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $4,067.28, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm-fixed price basis. The contract does not have a set-aside designation.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Armed Forces worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/11/24, 9:20 AM